Blood test identifies HPV-associated head and neck cancers up to 10 years before symptoms

Test detects HPV-associated head, neck cancer 10 years early — Harvard Gazette

Daniel Faden in his lab at Mass Eye and Ear. Mass Eye and Ear Health New blood test detects HPV-associated head and neck cancer 10 years early Tool identifies disease before symptoms appear Mass General Brigham Communications September 10, 2025 3 min read Human papillomavirus (HPV) causes an estimated 70 percent of head and neck cancers in the U.S., making it the most common cancer caused by the …

New blood test exhibits superior sensitivity in detecting HPV-associated head and neck cancers: Study

A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with significantly higher accuracy than currently used methods, including before...

Blood test identifies HPV-associated head and neck cancers up to 10 years before symptoms

Human papillomavirus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year. Unlike cervical cancers caused by HPV, there is no screening test for HPV-associated head and neck cancers. This means that patients are usually diagnosed after a tumor has grown to billions of cells in size, causing symptoms and spreading to lymph nodes. Screening meth…

Blood Test Detects HPV-Driven Head and Neck Cancer 10 Years Earlier

HPV-DeepSeek, a liquid biopsy test combining whole genome sequencing and machine learning technology, has been reported to accurately identify head and neck cancers caused by the human papilloma virus (HPV) up to 10 years before symptoms appear. Results published in the Journal of the National Cancer Institute showcase the potential of this test to enable earlier detection and treatment of a form of cancer that is often diagnosed years after ons…

New blood test detects head and neck cancer 10 years early

Head and neck cancers caused by human papillomavirus (HPV) are on the rise in the United States, now accounting for about 70 percent of cases. Yet unlike cervical cancer, which has routine HPV-based screening, there has been no test to detect HPV-related head and neck cancers before symptoms appear. Most patients are diagnosed only after […] The post New blood test detects head and neck cancer 10 years early appeared first on Knowridge Science R…

Blood Test Detects HPV-Linked Head and Neck Cancers Up to a Decade Before

Human papilloma virus (HPV) has long been recognized for its role in causing cervical cancer, but recent epidemiological shifts have placed HPV-associated head and neck cancers at the forefront of viral oncogenesis in the United States. Approximately 70 percent of head and neck cancers in the country are now attributable to HPV infection, with incidence […]